Johnson & Johnson's 'AAA' rating on Credit Watch Negative at S&P following Intra-Cellular Therapies acquisition
-- Johnson & Johnson (NYSE:JNJ)'s 'AAA' credit rating, as determined by S&P Global Ratings, is now under review due to the company's recent acquisition of...